CN107530361A - 用于调节骨密度的方法 - Google Patents
用于调节骨密度的方法 Download PDFInfo
- Publication number
- CN107530361A CN107530361A CN201680022614.7A CN201680022614A CN107530361A CN 107530361 A CN107530361 A CN 107530361A CN 201680022614 A CN201680022614 A CN 201680022614A CN 107530361 A CN107530361 A CN 107530361A
- Authority
- CN
- China
- Prior art keywords
- disease
- compound
- subject
- hydrogen
- hydroxyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- QRAFTOXKXUYZQL-ZRQVZWKASA-N CC[C@H](C)[C@H]([C@@H]([C@H](CC1)[C@](C)(CC2)[C@H]1C(C)CCC(O)=O)[C@H]2[C@](C)(CC1)CC[C@H]1O)O Chemical compound CC[C@H](C)[C@H]([C@@H]([C@H](CC1)[C@](C)(CC2)[C@H]1C(C)CCC(O)=O)[C@H]2[C@](C)(CC1)CC[C@H]1O)O QRAFTOXKXUYZQL-ZRQVZWKASA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/542—Carboxylic acids, e.g. a fatty acid or an amino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
- C07J9/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562130144P | 2015-03-09 | 2015-03-09 | |
| US62/130,144 | 2015-03-09 | ||
| PCT/US2016/021344 WO2016144946A1 (en) | 2015-03-09 | 2016-03-08 | Methods for modulating bone density |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107530361A true CN107530361A (zh) | 2018-01-02 |
Family
ID=56879295
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201680022614.7A Pending CN107530361A (zh) | 2015-03-09 | 2016-03-08 | 用于调节骨密度的方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20180042943A1 (https=) |
| EP (1) | EP3268009A4 (https=) |
| JP (1) | JP2018507880A (https=) |
| KR (1) | KR20170125927A (https=) |
| CN (1) | CN107530361A (https=) |
| AU (1) | AU2016229906A1 (https=) |
| CA (1) | CA2978916A1 (https=) |
| HK (1) | HK1243646A1 (https=) |
| IL (1) | IL254197A0 (https=) |
| MX (1) | MX2017011399A (https=) |
| SG (1) | SG11201707328SA (https=) |
| WO (1) | WO2016144946A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201812382D0 (en) | 2018-07-30 | 2018-09-12 | Nzp Uk Ltd | Compounds |
| US10919162B2 (en) | 2018-12-26 | 2021-02-16 | Ford Global Technologies, Llc | Systems and methods for efficient power management of modular mobile robot platforms with replaceable batteries |
| DE102020101118A1 (de) | 2019-01-18 | 2020-07-23 | Ford Global Technologies, Llc | Mobile mehrzweckroboter und verfahren zu deren verwendung |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7332276B2 (en) * | 2002-03-01 | 2008-02-19 | Celltech R&D, Inc. | Methods to increase or decrease bone density |
| US20050107475A1 (en) * | 2002-03-21 | 2005-05-19 | Jones Stacey A. | Methods of using farnesoid x receptor (frx) agonists |
| CL2007003035A1 (es) * | 2006-10-24 | 2008-05-16 | Smithkline Beechman Corp | Compuestos derivados de isoxazol sustituidos, agonistas de receptores farnesoid x; procedimiento de preparacion; composicion farmaceutica que lo comprende; y uso del compuesto en el tratamiento de la obesidad, diabetes mellitus, fibrosis en organos, |
| JP2012072095A (ja) * | 2010-09-29 | 2012-04-12 | Tokyo Institute Of Technology | 骨形成促進剤 |
| SI3336097T1 (sl) * | 2012-06-19 | 2021-07-30 | Intercept Pharmaceuticals, Inc. | Priprava nekristalinične oblike obetiholne kisline |
| WO2014021694A1 (ko) * | 2012-08-03 | 2014-02-06 | 서울대학교 산학협력단 | 골 관련 질환 예방 및 치료를 위한 조성물 |
| TN2015000497A1 (en) * | 2013-05-14 | 2017-04-06 | Intercept Pharmaceuticals Inc | 11-hydroxyl-derivatives of bile acids and amino acid conjugates thereof as farnesoid x receptor modulators |
-
2016
- 2016-03-08 CN CN201680022614.7A patent/CN107530361A/zh active Pending
- 2016-03-08 HK HK18103269.8A patent/HK1243646A1/zh unknown
- 2016-03-08 MX MX2017011399A patent/MX2017011399A/es unknown
- 2016-03-08 WO PCT/US2016/021344 patent/WO2016144946A1/en not_active Ceased
- 2016-03-08 SG SG11201707328SA patent/SG11201707328SA/en unknown
- 2016-03-08 JP JP2017547148A patent/JP2018507880A/ja active Pending
- 2016-03-08 US US15/556,514 patent/US20180042943A1/en not_active Abandoned
- 2016-03-08 CA CA2978916A patent/CA2978916A1/en not_active Abandoned
- 2016-03-08 EP EP16762337.0A patent/EP3268009A4/en not_active Withdrawn
- 2016-03-08 KR KR1020177027942A patent/KR20170125927A/ko not_active Withdrawn
- 2016-03-08 AU AU2016229906A patent/AU2016229906A1/en not_active Abandoned
-
2017
- 2017-08-29 IL IL254197A patent/IL254197A0/en unknown
Non-Patent Citations (2)
| Title |
|---|
| SIMON HOHENESTER等: "Primary biliary cirrhosis", 《SEMIN IMMUNOPATHOL》 * |
| SUN WOOK CHO等: "Positive Regulation of Osteogenesis by Bile Acid Through FXR", 《JOURNAL OF BONE AND MINERAL RESEARCH》 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CA2978916A1 (en) | 2016-09-15 |
| MX2017011399A (es) | 2018-03-16 |
| US20180042943A1 (en) | 2018-02-15 |
| EP3268009A4 (en) | 2018-12-12 |
| IL254197A0 (en) | 2017-10-31 |
| HK1243646A1 (zh) | 2018-07-20 |
| SG11201707328SA (en) | 2017-10-30 |
| JP2018507880A (ja) | 2018-03-22 |
| WO2016144946A1 (en) | 2016-09-15 |
| EP3268009A1 (en) | 2018-01-17 |
| AU2016229906A1 (en) | 2017-09-21 |
| KR20170125927A (ko) | 2017-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Yan et al. | Oryzanol alleviates high fat and cholesterol diet-induced hypercholesterolemia associated with the modulation of the gut microbiota in hamsters | |
| US6426340B1 (en) | Prevention and treatment of colorectal cancer by 6-fluoroursodeoxycholic acid (6-FUDCA) | |
| CN107405325B (zh) | 用于组合疗法的药物组合物 | |
| CN113164498A (zh) | 用于肝病的治疗的组合疗法 | |
| US20160354387A1 (en) | Pharmaceutical composition based on a hepatoprotector and a prebiotic, and production and application thereof | |
| US20230138455A1 (en) | METHODS OF DOSING OF APICAL SODIUM-DEPENDENT BILE ACID TRANSPORTER INHIBITORS (ASBTIs) | |
| WO2023081370A1 (en) | Treatment with ileal bile acid transporter (ibat) inhibitors for increased event-free survival (efs) | |
| CN107530361A (zh) | 用于调节骨密度的方法 | |
| EA014077B1 (ru) | Применение 24-нор-урсодеоксихолевой кислоты | |
| CA2721728A1 (en) | Treatment of inflammatory bowel disease with 6-mercaptopurine | |
| US20190365697A1 (en) | Method for Treating Liver Dysfunction | |
| WO2019004465A1 (ja) | ペマフィブラートを含有する医薬 | |
| US10398717B2 (en) | Pharmaceutical composition based on a hepatoprotector and prebiotic, and method for administrating | |
| WO2022237731A1 (zh) | 一种治疗高脂血症的药物组合物及其制备方法 | |
| WO2020240483A1 (en) | Combination of a polyhydroxylated bile acid and a farnesoid x receptor agonist | |
| US20240100001A1 (en) | Denatonium salt for use in preventing, preventing progression and treating fatty liver diseases | |
| TWI612959B (zh) | 含有亞鐵胺基酸螯合物之組合物用於製造治療肝功能異常之醫藥品的用途 | |
| TWI228992B (en) | Treatment of subnormal bone mineral density | |
| HK40092040B (en) | Treatment of cholangiopathies with seladelpar | |
| JPH04266822A (ja) | システノール酸又はその胆汁酸抱合体を含有する血中コレステロール低下剤 | |
| van Vliet et al. | Renger G. Tiessen1, Ciara A. Kennedy2, Bradley T. Keller2, Nancy Levin2, Lisette Acevedo2, Bronislava Gedulin2 | |
| Mayo | Non-PBC, Non-PSC autoimmune cholangiopathy | |
| Kale et al. | Recent research on orphan drugs: An overview | |
| JP2002068985A (ja) | 薬剤性肝障害治療薬 | |
| HK1246191B (zh) | 用於组合疗法的药物组合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1243646 Country of ref document: HK |
|
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20180102 |
|
| WD01 | Invention patent application deemed withdrawn after publication | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1243646 Country of ref document: HK |